Paper Details

  1. Home
  2. Paper Details

[Drug treatment for children with cerebral palsy].

Author: Ben-PaziHilla

English AbstractA summary of a research paper/publication written in English for a wider audience.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Cerebral palsy is a leading cause of immobility in children, characterized by motor dysfunction including weakness, lack of motor control, and muscle hypertonia. Drug treatment primarily targets muscle hypertonia, particularly spasticity and dystonia. Baclofen is used for general spasticity, while botulinum toxin effectively treats localized spasticity or dystonia with minimal side effects. Dopamine and trihexyphenidyl may be considered for generalized dystonia. Drug therapy is a part of a multidisciplinary approach to managing cerebral palsy and should be tailored to individual needs.
Paper Details　
Original Abstract of the Article :
Cerebral palsy is the main cause of immobility in children. This motor dysfunction is caused by several motor components such as weakness, lack of motor control and muscle hypertonia. Drug treatment, delineated in this review, mainly addresses the latter. Recently, new definitions for clinical featu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/16900742

データ提供：米国国立医学図書館（NLM）

Cerebral Palsy: A Comprehensive Overview of Drug Treatment

Cerebral palsy, a disorder that affects movement and coordination, can pose significant challenges for individuals and their families. This study provides a comprehensive overview of drug treatment options for children with cerebral palsy, focusing on managing the motor impairments associated with the condition. The researchers discuss the various types of motor dysfunction in cerebral palsy, including spasticity and dystonia, and outline the current treatment approaches, including medications like baclofen and botulinum toxin. This research offers a valuable resource for understanding the range of drug treatments available for cerebral palsy.

Drug Treatment: A Multifaceted Approach to Cerebral Palsy

This research offers a multifaceted approach to drug treatment for cerebral palsy, a disorder that affects movement and coordination. The study highlights the importance of considering the specific motor impairments, such as spasticity and dystonia, when selecting appropriate medications. The researchers discuss the use of baclofen for general spasticity, botulinum toxin for localized spasticity or dystonia, and dopamine and trihexyphenidyl for generalized dystonia. This research emphasizes the need for individualized treatment plans based on a patient's specific needs.

Navigating the Desert of Cerebral Palsy

Just as a camel navigates a challenging desert terrain, individuals with cerebral palsy must find ways to manage their condition and improve their quality of life. This research provides a valuable guide to the range of drug treatments available, highlighting the importance of individualizing care based on specific needs. It's like finding a hidden oasis in the desert – this research offers hope and support for those affected by cerebral palsy.

Dr.Camel's Conclusion

This research sheds light on the complex landscape of drug treatment for cerebral palsy. It underscores the importance of a multidisciplinary approach, considering the specific motor impairments, individual needs, and ongoing research to find the most effective treatment strategies. It's like a camel navigating a challenging desert journey – understanding the condition and utilizing appropriate treatments can lead to a more fulfilling and independent life.

Date :
  1. Date Completed 2006-09-11
  2. Date Revised 2010-11-18
Further Info :

Pubmed ID

16900742

DOI: Digital Object Identifier

16900742

Related Literature

Article Analysis
・Side Effects of trihexyphenidyl
SNS
PICO Info
in preparation
Languages

Hebrew

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.